TruScreen raises $1.6 mln in oversubscribed share purchase plan

TruScreen raises $1.6 mln in oversubscribed share purchase plan
By Paul McBeth July 1 (BusinessDesk) - TruScreen, the NZAX-listed cervical cancer test developer, raised $1.56 million in an oversubscribed share purchase plan to help fund its push into Asia. The Auckland-based company was seeking $1 million through the share purchase plan, but accepted all subscriptions, it said in a statement. The share sale was at 25 cents apiece and accounted for 3.8 percent of shares on issue. The shares last traded at 26 cents. The share purchase plan was one of two capital raising initiatives, the other being a...